Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


20.03.2017

1 Addict Behav
1 Am J Med Genet B Neuropsychiatr Genet
2 Br J Psychiatry
1 Brain Res
2 J Clin Psychiatry
1 J Clin Psychopharmacol
1 J Int Neuropsychol Soc
4 Mol Psychiatry
2 Neuropsychopharmacology
5 Psychiatry Res
1 Psychophysiology
14 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Addict Behav

  1. SCHUSTER RM, Cather C, Pachas GN, Zhang H, et al
    Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.
    Addict Behav. 2017;71:89-95.
    PubMed     Text format     Abstract available


    Am J Med Genet B Neuropsychiatr Genet

  2. VAN DER AUWERA S, Wittfeld K, Shumskaya E, Bralten J, et al
    Predicting brain structure in population-based samples with biologically informed genetic scores for schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet. 2017;174:324-332.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  3. LASALVIA A, Bonetto C, Lenzi J, Rucci P, et al
    Predictors and moderators of treatment outcome in patients receiving multi-element psychosocial intervention for early psychosis: results from the GET UP pragmatic cluster randomised controlled trial.
    Br J Psychiatry. 2017 Mar 16. pii: bjp.bp.116.190058.
    PubMed     Text format     Abstract available

  4. LUTGENS D, Gariepy G, Malla A
    Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-analysis.
    Br J Psychiatry. 2017 Mar 16. pii: bjp.bp.116.197103.
    PubMed     Text format     Abstract available


    Brain Res

  5. CURRIE J, Buruju D, Perrin JS, Reid IC, et al
    Schizophrenia illness severity is associated with reduced loss aversion.
    Brain Res. 2017 Mar 10. pii: S0006-8993(17)30114.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  6. KASTER TS, Daskalakis ZJ, Blumberger DM
    Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10686.
    PubMed     Text format     Abstract available

  7. GERRETSEN P, Voineskos AN, Graff-Guerrero A, Menon M, et al
    Insight Into Illness and Cognition in Schizophrenia in Earlier and Later Life.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10741.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  8. YOSHIMURA Y, Takeda T, Kishi Y, Harada T, et al
    Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
    J Clin Psychopharmacol. 2017 Mar 17. doi: 10.1097/JCP.0000000000000689.
    PubMed     Text format     Abstract available


    J Int Neuropsychol Soc

  9. KURTZ MM, Trask CL, Rosengard R, Hyman S, et al
    Verbal Learning and Memory Enhancement Strategies in Schizophrenia: A Randomized, Controlled Investigation.
    J Int Neuropsychol Soc. 2017 Mar 13:1-6. doi: 10.1017/S1355617717000042.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  10. CHANG H, Xiao X, Li M
    The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available

  11. PAGE SC, Hamersky GR, Gallo RA, Rannals MD, et al
    The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available

  12. ROFFMAN JL, Petruzzi LJ, Tanner AS, Brown HE, et al
    Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available

  13. ORHAN F, Fatouros-Bergman H, Goiny M, Malmqvist A, et al
    CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  14. SARPAL DK, Robinson DG, Fales C, Lencz T, et al
    Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia.
    Neuropsychopharmacology. 2017 Mar 15. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available

  15. POGORELOV VM, Rodriguiz RM, Cheng J, Huang M, et al
    5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.
    Neuropsychopharmacology. 2017 Mar 15. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    Psychiatry Res

  16. RIBOLSI M, Lin A, Wardenaar KJ, Pontillo M, et al
    Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect?
    Psychiatry Res. 2017;252:169-174.
    PubMed     Text format     Abstract available

  17. MCKETIN R, Baker AL, Dawe S, Voce A, et al
    Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    Psychiatry Res. 2017;251:349-354.
    PubMed     Text format     Abstract available

  18. CHU CS, Chow PC, Cohen-Woods S, Gaysina D, et al
    The DAOA gene is associated with schizophrenia in the Taiwanese population.
    Psychiatry Res. 2017;252:201-207.
    PubMed     Text format     Abstract available

  19. BOLINSKEY PK, Smith EA, Schuder KM, Cooper-Bolinskey D, et al
    Schizophrenia spectrum personality disorders in psychometrically identified schizotypes at two-year follow-up.
    Psychiatry Res. 2017;252:289-295.
    PubMed     Text format     Abstract available

  20. YU LQ, Lee S, Katchmar N, Satterthwaite TD, et al
    Steeper discounting of delayed rewards in schizophrenia but not first-degree relatives.
    Psychiatry Res. 2017;252:303-309.
    PubMed     Text format     Abstract available


    Psychophysiology

  21. BOUDEWYN MA, Carter CS
    Electrophysiological correlates of adaptive control and attentional engagement in patients with first episode schizophrenia and healthy young adults.
    Psychophysiology. 2017 Mar 15. doi: 10.1111/psyp.12820.
    PubMed     Text format     Abstract available


    Schizophr Res

  22. GALLETLY C, Dhillon VS, Liu D, Balzan RP, et al
    Shorter telomere length in people with schizophrenia: A preliminary study from Australia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30128.
    PubMed     Text format     Abstract available

  23. HARTZ SM, Horton AC, Hancock DB, Baker TB, et al
    Genetic correlation between smoking behaviors and schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30111.
    PubMed     Text format     Abstract available

  24. TAKASE M, Kanahara N, Oda Y, Niitsu T, et al
    The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30136.
    PubMed     Text format    

  25. VALAPARLA VL, Nehra R, Mehta UM, Thirthalli J, et al
    Social cognition of patients with schizophrenia across the phases of illness - A longitudinal study.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30123.
    PubMed     Text format     Abstract available

  26. OKRUSZEK L, Pilecka I
    Biological motion processing in schizophrenia - Systematic review and meta-analysis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30135.
    PubMed     Text format     Abstract available

  27. KHOKHAR JY, Todd TP
    Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30118.
    PubMed     Text format     Abstract available

  28. BARBATO M, Buchy L, Bray S, MacMaster F, et al
    Testing the feasibility of a computerized facial affect recognition training in early psychosis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30137.
    PubMed     Text format    

  29. EACK SM, Wojtalik JA, Keshavan MS, Minshew NJ, et al
    Social-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30130.
    PubMed     Text format     Abstract available

  30. AWAN NR, Jehangir SF, Irfan M, Naeem F, et al
    Explanatory model of illness of the patients with schizophrenia and the role of educational intervention.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30125.
    PubMed     Text format     Abstract available

  31. KOZAK K, Dermody SS, Rabin RA, Zack M, et al
    Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30143.
    PubMed     Text format    

  32. BORA E
    Relationship between insight and theory of mind in schizophrenia: A meta-analysis.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30167.
    PubMed     Text format     Abstract available

  33. FU S, Czajkowski N, Rund BR, Torgalsboen AK, et al
    The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30122.
    PubMed     Text format     Abstract available

  34. LUDWIG KA, Pinkham AE, Harvey PD, Kelsven S, et al
    Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30121.
    PubMed     Text format     Abstract available

  35. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30129.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: